ArticlePloS one2022

Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients.

Neneng Ratnasari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.